NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|42566423|gb|AAS21042|]
View 

glycoprotein I [Bovine herpesvirus 5 strain TX89]

Protein Classification

PHA03292 family protein( domain architecture ID 11476199)

PHA03292 family protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-387 1.45e-156

envelope glycoprotein I; Provisional


:

Pssm-ID: 177577  Cd Length: 413  Bit Score: 447.10  E-value: 1.45e-156
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    1 MRCLLLFWVAALAARAAPASGLVYRGEAVGLRADGPVAFAVHPADATLALRGRLIFLEHQLPAGRRYNGTVELLRYLVDG 80
Cdd:PHA03292   2 AKCALLFWAAILLAIAACATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSS 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   81 DCFVMLQATAFASCPRVANDAFRSCLHADTRPARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGIDGGAEGaerrrD 160
Cdd:PHA03292  82 DCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTA-----D 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  161 VFPLAAFVHGFDGPGSDDPEAATARPGGAAGAIAAHCERGLNAGSASLYDRAMAAFPAGAAAATPTPAADGGGEGVATPD 240
Cdd:PHA03292 157 VFGLSAFVYDFDSPTVPDPEPTTARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQPAGAATATPTPTLDTGLTTVAPPN 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  241 QAGETSET---------------------GTRASLTPDPAATPTPPATPPAPADNSSSRTPGAAGAAAQSPQDTPARFQR 299
Cdd:PHA03292 237 ETVVTGETallchwfqpstrvptlylhllGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSPKRRNK 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  300 QLASILVPLCVLVLLLLALCAAMANCAMRRRLLPC-SRRIYKPRTCAACGSG----TCAGRPPCRGAAPIAPATVVTLES 374
Cdd:PHA03292 317 IVAMIVIPTACVVLLLLAVVGAIINGAVRKHLLSCaSRRIYRPRQGGASSSErrrlTCGPTPAASSESLADDTTVSPPSS 396
                        410
                 ....*....|....*.
gi 42566423  375 RPKAPP---LATISEE 387
Cdd:PHA03292 397 KPKAKPkrkLEAIKEE 412
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-387 1.45e-156

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 447.10  E-value: 1.45e-156
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    1 MRCLLLFWVAALAARAAPASGLVYRGEAVGLRADGPVAFAVHPADATLALRGRLIFLEHQLPAGRRYNGTVELLRYLVDG 80
Cdd:PHA03292   2 AKCALLFWAAILLAIAACATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSS 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   81 DCFVMLQATAFASCPRVANDAFRSCLHADTRPARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGIDGGAEGaerrrD 160
Cdd:PHA03292  82 DCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTA-----D 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  161 VFPLAAFVHGFDGPGSDDPEAATARPGGAAGAIAAHCERGLNAGSASLYDRAMAAFPAGAAAATPTPAADGGGEGVATPD 240
Cdd:PHA03292 157 VFGLSAFVYDFDSPTVPDPEPTTARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQPAGAATATPTPTLDTGLTTVAPPN 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  241 QAGETSET---------------------GTRASLTPDPAATPTPPATPPAPADNSSSRTPGAAGAAAQSPQDTPARFQR 299
Cdd:PHA03292 237 ETVVTGETallchwfqpstrvptlylhllGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSPKRRNK 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  300 QLASILVPLCVLVLLLLALCAAMANCAMRRRLLPC-SRRIYKPRTCAACGSG----TCAGRPPCRGAAPIAPATVVTLES 374
Cdd:PHA03292 317 IVAMIVIPTACVVLLLLAVVGAIINGAVRKHLLSCaSRRIYRPRQGGASSSErrrlTCGPTPAASSESLADDTTVSPPSS 396
                        410
                 ....*....|....*.
gi 42566423  375 RPKAPP---LATISEE 387
Cdd:PHA03292 397 KPKAKPkrkLEAIKEE 412
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
4-165 8.99e-19

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 82.56  E-value: 8.99e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423     4 LLLFWVAALaaraapaSGLVYRGEAVGLRADGPVAFAVHPAD--ATLALRGRLIFLEHQLPAGRRYNGTVELLRYLVDGD 81
Cdd:pfam01688   4 AVGFWICLT-------TGLVVKGPTVSLVSDSSLDVGACGPDkvVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGK 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    82 CFVMLQATAFASCPRVANDAFRSCLHADTRP-ARSERRVSAAVEnhvLFSIAGPRPADSGLYFLRVGIDGgaegaERRRD 160
Cdd:pfam01688  77 CPRVVHVVRYTACPRIPAVAFSGCRRTDSEHyPTPEDRLATQPG---LLRIRTPTRDDAGVYVLRVWLDH-----APNAD 148

                  ....*
gi 42566423   161 VFPLA 165
Cdd:pfam01688 149 AFRLG 153
 
Name Accession Description Interval E-value
PHA03292 PHA03292
envelope glycoprotein I; Provisional
1-387 1.45e-156

envelope glycoprotein I; Provisional


Pssm-ID: 177577  Cd Length: 413  Bit Score: 447.10  E-value: 1.45e-156
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    1 MRCLLLFWVAALAARAAPASGLVYRGEAVGLRADGPVAFAVHPADATLALRGRLIFLEHQLPAGRRYNGTVELLRYLVDG 80
Cdd:PHA03292   2 AKCALLFWAAILLAIAACATGIVYRGEHVSLYLDASSEFAVYPTDASLVLVGHLIFLDGQRLPTTNYNGTIELIHYNYSS 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   81 DCFVMLQATAFASCPRVANDAFRSCLHADTRPARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGIDGGAEGaerrrD 160
Cdd:PHA03292  82 DCYVVIQTISYESCPRVANNAFRSCLHKTSRHNRDYFRVNASVETNVLLNITGPQPADSGAYILRVKLDHAPTA-----D 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  161 VFPLAAFVHGFDGPGSDDPEAATARPGGAAGAIAAHCERGLNAGSASLYDRAMAAFPAGAAAATPTPAADGGGEGVATPD 240
Cdd:PHA03292 157 VFGLSAFVYDFDSPTVPDPEPTTARPEPAAGYVATPTPRYLNAVTTSTYSRSMSSQPAGAATATPTPTLDTGLTTVAPPN 236
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  241 QAGETSET---------------------GTRASLTPDPAATPTPPATPPAPADNSSSRTPGAAGAAAQSPQDTPARFQR 299
Cdd:PHA03292 237 ETVVTGETallchwfqpstrvptlylhllGTTGNLTEDVLLTEDSEILRTPPPDPSSSRSPGAGDDFKQTNSTSPKRRNK 316
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423  300 QLASILVPLCVLVLLLLALCAAMANCAMRRRLLPC-SRRIYKPRTCAACGSG----TCAGRPPCRGAAPIAPATVVTLES 374
Cdd:PHA03292 317 IVAMIVIPTACVVLLLLAVVGAIINGAVRKHLLSCaSRRIYRPRQGGASSSErrrlTCGPTPAASSESLADDTTVSPPSS 396
                        410
                 ....*....|....*.
gi 42566423  375 RPKAPP---LATISEE 387
Cdd:PHA03292 397 KPKAKPkrkLEAIKEE 412
PHA03289 PHA03289
envelope glycoprotein I; Provisional
1-168 3.56e-19

envelope glycoprotein I; Provisional


Pssm-ID: 165546  Cd Length: 352  Bit Score: 87.67  E-value: 3.56e-19
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    1 MRCLLLFWVAALAARAApasgLVYRGEAVGLRADGPVAFAVHPADATLALRGRLIFLEHQLPAgRRYNGTVELLRYLVDG 80
Cdd:PHA03289   2 MVCVTLILFCLIIGTQS----MVYTGTSVSTSTDQSAQVAFCGLDKVVNVYGKLLFLGDQYLE-ESYSGTTEILKWNEAN 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   81 DCFVMLQATAFASCPRVANDAFRSCLHADTRpARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGIDGgaegaERRRD 160
Cdd:PHA03289  77 KCYSVAHATYYADCPIISSTVFRGCRDAVVY-ARPHDRVHPQYEKGLLLTIIEPRMSDTGIYYIRVSLAG-----RNKSD 150

                 ....*...
gi 42566423  161 VFPLAAFV 168
Cdd:PHA03289 151 IFRTSVFV 158
Herpes_gI pfam01688
Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members ...
4-165 8.99e-19

Alphaherpesvirus glycoprotein I; This family consists of glycoprotein I form various members of the alphaherpesvirinae these include herpesvirus, varicella-zoster virus and pseudorabies virus. Glycoprotein I (gI) is important during natural infection, mutants lacking gI produce smaller lesions at the site of infection and show reduced neuronal spread. gI forms a heterodimeric complex with gE; this complex displays Fc receptor activity (binds to the Fc region of immunoglobulin). Glycoproteins are also important in the production of virus-neutralising antibodies and cell mediated immunity. The alphaherpesvirinae have a dsDNA gnome and have no RNA stage during viral replication.


Pssm-ID: 279953  Cd Length: 155  Bit Score: 82.56  E-value: 8.99e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423     4 LLLFWVAALaaraapaSGLVYRGEAVGLRADGPVAFAVHPAD--ATLALRGRLIFLEHQLPAGRRYNGTVELLRYLVDGD 81
Cdd:pfam01688   4 AVGFWICLT-------TGLVVKGPTVSLVSDSSLDVGACGPDkvVEEDVGGQLVFLGDQVPTTNYYDGTVELLHYPEGGK 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    82 CFVMLQATAFASCPRVANDAFRSCLHADTRP-ARSERRVSAAVEnhvLFSIAGPRPADSGLYFLRVGIDGgaegaERRRD 160
Cdd:pfam01688  77 CPRVVHVVRYTACPRIPAVAFSGCRRTDSEHyPTPEDRLATQPG---LLRIRTPTRDDAGVYVLRVWLDH-----APNAD 148

                  ....*
gi 42566423   161 VFPLA 165
Cdd:pfam01688 149 AFRLG 153
PHA03290 PHA03290
envelope glycoprotein I; Provisional
1-149 1.98e-14

envelope glycoprotein I; Provisional


Pssm-ID: 165547  Cd Length: 357  Bit Score: 73.90  E-value: 1.98e-14
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423    1 MRCLLLFWVAALAARaapaSGLVYRGEAVGLRADGPVAFAVHPA--DATLALRGRLIFLEHQLPAGRRYNGTVELLRYLV 78
Cdd:PHA03290   4 IQCLISAMIFGIQCA----AAIIFKGDHISLQVNSSATSIFIKMgnDNDAEIKGQFLFIGDQFPTGNNYNGTLELLHADQ 79
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 42566423   79 DGDCFVMLQATAFASCPRVANDAFRSCLHADT-RPARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGID 149
Cdd:PHA03290  80 TAFCFQPLQRIMYDECPRIRTGAFIACRVKHSwHYENATDRILTDPDAEIIFKINKPGIEDAGIYLLLVQLD 151
PHA03291 PHA03291
envelope glycoprotein I; Provisional
20-179 2.01e-04

envelope glycoprotein I; Provisional


Pssm-ID: 223033 [Multi-domain]  Cd Length: 401  Bit Score: 43.02  E-value: 2.01e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   20 SGLVYRGEAVGLRADGPVAFAVHPADAT----LALRGRLIFLEHQLPAGRRYNGTVELLRYLVDGDCFVMLQATAFASCP 95
Cdd:PHA03291  18 AGVVVRGPTISLVSDSLLAAGAVGADGSvledLEVPGELHFLGPQVPHTTYYDGAVELFHYPPGDRCPRVVLVEELTACP 97
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 42566423   96 RVANDAFRSCLHADTRPARSERRVSAAVENHVLFSIAGPRPADSGLYFLRVGIdGGAEGAERrrdvFPLAAFVHGFDGPG 175
Cdd:PHA03291  98 RRPAVAFTLCRSTRRTQSPAYATLTLDLARQPLLRARGAARAVVGLYVLRVWV-EGATNASL----FPLGLAAFPAEGTL 172

                 ....
gi 42566423  176 SDDP 179
Cdd:PHA03291 173 AAPP 176
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH